ECONOMIC IMPACT OF AFLIBERCEPT OPTIMISATION FOR THE TREATMENT OF AGE RELATED MACULAR DEGENERATION REFRACTORY TO BEVACIZUMAB AND/ OR RANIBIZUMAB

ECONOMIC IMPACT OF AFLIBERCEPT OPTIMISATION FOR THE TREATMENT OF AGE RELATED MACULAR DEGENERATION REFRACTORY TO BEVACIZUMAB AND/ OR RANIBIZUMAB